Doxorubicin Archives - Medical Conferences

POLARIX: Novel regimen superior to R-CHOP in DLBCL

Presented By

Prof. Hervé Tilly, University of Rouen, France

Trial

Phase 3, POLARIX

Conference

ASH 2021

Type

Peer-reviewed article

4 February 2022 10:56

ASH 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ASH 2021

4 January 2022 08:00

Better survival with neoadjuvant dose-dense MVAC regimen in MIBC

Presented By

Dr Christian Pfister, Rouen University Hospital, France

Trial

Phase 3, VESPER

Conference

ESMO 2021

Type

Peer-reviewed article

19 November 2021 09:25

Immuno-oncology agents are effective in treating classic Hodgkin’s lymphoma

Presented By

Dr Marc André, Centre Hospitalier Universitaire UCL Namur, Belgium

Trial

CheckMate 205; KEYNOTE-087

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 12:26

Treatment of recurrent ovarian cancer

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:35

High rates of ROR-low disease with chemotherapy-free regimen in HR+/HER2- patients

Trial

Phase 2, CORALLEEN

Conference

SABCS 2019

Type

Peer-reviewed article

13 February 2020 23:05

No added benefit for doxorubicin + docetaxel vs doxorubicin + cyclophosphamide

Conference

SABCS 2019

Type

Peer-reviewed article

13 February 2020 12:51

Brentuximab vedotin continues to demonstrate superior clinical activity in classical Hodgkin lymphoma

Presented By

Dr Steven Horwitz , Memorial Sloan Kettering Cancer Center, USA

Trial

Phase 3, ECHELON-1

Conference

EHA 2019

Type

Peer-reviewed article

9 August 2019 20:49